Legal Representation
Attorney
Charles T. J. Weigell
USPTO Deadlines
Next Deadline
553 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-01-26)
Due Date
January 26, 2027
Grace Period Ends
July 26, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
37 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 4, 2021 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| May 23, 2021 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Apr 29, 2021 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Apr 29, 2021 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Apr 26, 2021 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Jan 26, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Nov 10, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 10, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 8, 2020 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Oct 21, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 21, 2020 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Oct 21, 2020 | LIMN | I | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | Loading... |
| Oct 21, 2020 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Oct 5, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Oct 5, 2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 5, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 5, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Oct 5, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 18, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 18, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 18, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 27, 2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jul 27, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jul 27, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jul 27, 2020 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | Loading... |
| Jul 27, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jul 27, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| May 22, 2020 | LIMG | M | LIMITATION OF GOODS RECEIVED FROM IB | Loading... |
| Apr 17, 2020 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Mar 31, 2020 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Mar 31, 2020 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Mar 17, 2020 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Mar 16, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 16, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 28, 2020 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Feb 24, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 20, 2020 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations and biologic medicines used in the treatment of angiogenesis and ocular diseases and disorders as well as angiogenesis and ocular conditions related to diabetic, oncological, macular and vascular diseases and disorders; dietetic food adapted for medical use; dietary supplements for humans
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
Applicators in the nature of droppers sold empty and syringes for administering medications into the human eye; medical apparatus for introducing pharmaceutical preparations into the human body; diagnostic apparatus for detecting angiogenesis and ocular diseases and disorders
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Translation
The wording "XIMLUCI" has no meaning in a foreign language.
Classification
International Classes
005
010